Researchers conducted a single-center cohort study of more than 47,000 patients diagnosed with CRC from January 1, 1973, to ...

Taking race into account when developing tools to predict a patient's risk of colorectal cancer leads to more accurate ...

The Affordable Care Act (ACA) has led to increased guideline-concordant care for colon cancer among non-white patients, ...

Gladys didn't expect to be diagnosed with the same cancer as her late husband. Discover the home tests that are empowering ...

Patients who are overweight when they're first diagnosed with cancer may be at higher risk of developing a second cancer.

Innovent Biologics has made the case that its checkpoint inhibitor-cytokine fusion protein has a future in colorectal cancer.

Vulnerable patients facing social, environmental, and economic disadvantages often experience worse cancer outcomes than other groups.

Treatment with Cyramza plus Lonsurf did not improve overall survival compared with Lonsurf alone in heavily pretreated ...

Researchers investigated the efficacy of total neoadjuvant treatment followed by nonoperative management in patients with locally advanced rectal cancer.

Researchers also noticed that the mice used as models for Alzheimer’s disease who were given stool transplants from healthy ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...